Press Resease

Whole Genome Amplification Market - Global Industry Analysis

Whole Genome Amplification Market - By Type (Complete WGA Kit, Single Cell WGA Kit, WGA & Chip DNA Kit, WGA Reamplification Kit, and Others), By Application (Disease Diagnosis, Drug Discovery & Development, Research, Agriculture & Veterinary, Forensics, and Others), By End-User (Hospitals & Clinics, Pharmaceutical & Biotech Companies, Organizations, Contract Research, Research & Academic Institutes, and Others), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Published Date: 15-Mar-2021 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3406 Status : Published

The global Whole Genome Amplification market, which accrued revenue worth 2.5 (USD Million) in 2019 and anticipated to garner earnings about 4.5 (USD Million) by 2025, is set to grow at a CAGR of nearly 7.9% during the period from 2019 to 2025.

Description

The global Whole Genome Amplification market, which accrued revenue worth 2.5 (USD Million) in 2019 and anticipated to garner earnings about 4.5 (USD Million) by 2025, is set to grow at a CAGR of nearly 7.9% during the period from 2019 to 2025. The report offers valuation and analysis of the Whole Genome Amplification market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, restraints, revenue estimates, avenues, current & emerging trends, and industry-validated market information. The report offers historical data from 2015 to 2018 along with a forecast from 2019 to 2025 based on value (USD Million).

Whole Genome Amplification Market: Outlook

Whole genome amplification is a methodology for amplifying complete genome commencing with nanogram DNA quantities and outputting microgram quantities of amplified products.  It is a major tool for preservation of limited samples of DNA products and has been utilized for amplifying material from a single DNA cell. Many methods have been developed for whole genome amplification and this comprises of degenerate oligonucleotide PCR, primer extension preamplification, and multiple displacement amplification.

Global Whole Genome Amplification Market

Whole Genome Amplification Market: Growth Drivers

Surge in the aging population along with increase in the cases of chronic diseases such as arthritis, heart disorders, and cancer will result in humungous growth of whole genome amplification industry over the forecast timeline. A massive rise in the allocation of funds for carrying out clinical trials is expected to offer new opportunities of growth for whole genome amplication industry over the assessment timeline. According to one such study carried out by NIH researchers w.r.t whole genome amplification made from as single cell and from the findings of the study, it has been concluded  that whole genome amplification is useful for diagnosis of genetic disease & forensics as well as accurately analyzing old samples of DNA. This will help in increasing the significance of whole genome amplification and will result in manifold growth of the market in the coming decade.

Furthermore, NCBI has stated that the use of whole genome amplification has gained momentum since last few years and polymerase chain reaction is used for replicating genomes of biological interest. Moreover, whole genome amplification finds a slew of applications including determining embryonic disorders, bioterrorism through genome detection, microbe diversity, genotyping, and clinical sample immortalization. Moreover, whole genome amplication has opened new vistas of growth for molecular biology domain. All these aforementioned factors are anticipated to help whole genome amplication industry mark a remarkable surge over the forecast timeframe.

North American Market To Witness Acceleration In Growth By 2025

The expansion of whole genome amplification industry in North America over the forecast timespan is owing to massive allocation of funds by the U.S. government for carrying out research pertaining to genetic disorders as well as forensic science. Apart from this, rise in the number of pharma firms in the countries such as Canada and the U.S. focusing on whole genome amplification activities will further proliferate the expansion of whole genome amplification market in the sub-continent over the assessment period. In addition to this, thriving genetic engineering domain in the sub-continent will make remarkable contributions towards the whole genome amplification market size in the years ahead.

Key participants profiled in the study include Qiagen NV, LGC Group, Sigma-Aldrich, and GE Healthcare.

The global whole genome amplification market is segmented as follows:

By type:

  • Single Cell WGA Kit
  • Complete WGA Kit
  • WGA Reamplification Kit
  • WGA & Chip DNA Kit
  • Others

By application:

  • Drug Discovery & Development
  • Disease Diagnosis
  • Agriculture & Veterinary
  • Research
  • Forensics
  • Others

By end-user:

  • Pharmaceutical & Biotech Companies
  • Contract Research
  • Hospitals & Clinics
  • Research & Academic Institutes
  • Organizations
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Whule Genome Amplification Market, 2015–2025 (USD Million)
    • 2.2. Whule Genome Amplification Market: Snapshot
  • Chapter 3. Global Whule Genome Amplification Market– Industry Analysis
    • 3.1. Whule Genome Amplification Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Massive need of robust and secured workwear at workplace to prevent cullisions will pruliferate the expansion of Whule Genome Amplification Market in the ensuing years.
      • 3.2.2. Swift industrialization owing to enhanced economic conditions witnessed across the developing countries has translated into humungous expansion of manufacturing as well as construction industries. This, in turn, has boosted the product End-User in the recent years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Type
      • 3.4.2. Market attractiveness analysis By End-User
  • Chapter 4. Global Whule Genome Amplification Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Whule Genome Amplification Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Whule Genome Amplification Market– Type Analysis
    • 5.1. Global Whule Genome Amplification Market overview: By Type
      • 5.1.1. Global Whule Genome Amplification Market share, By Type , 2018 and 2025
    • 5.2. Complete WGA Kit
      • 5.2.1. Global Whule Genome Amplification Market By Complete WGA Kit , 2015–2025 (USD Million)
    • 5.3. Single Cell WGA Kit
      • 5.3.1. Global Whule Genome Amplification Market By Anti-Static Workwear, 2015–2025 (USD Million)
    • 5.4. WGA & Chip DNA Kit
      • 5.4.1. Global Whule Genome Amplification Market By WGA & Chip DNA Kit, 2015–2025 (USD Million)
    • 5.5. WGA Reamplification Kit
      • 5.5.1. Global Whule Genome Amplification Market By WGA Reamplification Kit, 2015–2025 (USD Million)
    • 5.6. Others
      • 5.6.1. Global Whule Genome Amplification MarketBy Others, 2015–2025 (USD Million)
  • Chapter 6. Global Whule Genome Amplification Market– End-User Analysis
    • 6.1. Global Whule Genome Amplification Marketoverview: By End-User
      • 6.1.1. Global Whule Genome Amplification Marketshare, By End-User , 2018 and 2025
    • 6.2. Hospitals & Clinics
      • 6.2.1. Global Whule Genome Amplification MarketBy Hospitals & Clinics , 2015–2025 (USD Million)
    • 6.3. Pharmaceutical & Biotech Companies
      • 6.3.1. Global Whule Genome Amplification MarketBy Pharmaceutical & Biotech Companies, 2015–2025 (USD Million)
    • 6.4. Organizations
      • 6.4.1. Global Whule Genome Amplification Market By Organizations, 2015–2025 (USD Million)
    • 6.5. Contract Research
      • 6.5.1. Global Whule Genome Amplification Market By Contract Research , 2015–2025 (USD Million)
    • 6.6. Research & Academic Institutes
      • 6.6.1. Global Whule Genome Amplification Market By Research & Academic Institutes, 2015–2025 (USD Million)
    • 6.7. Others
      • 6.7.1. Global Whule Genome Amplification Market By Others, 2015–2025 (USD Million)
  • Chapter 7. Global Whule Genome Amplification Market– Application Analysis
    • 7.1. Global Whule Genome Amplification Market overview: By Application
      • 7.1.1. Global Whule Genome Amplification Market share, By Application , 2018 and 2025
    • 7.2. Disease Diagnosis
      • 7.2.1. Global Whule Genome Amplification Market By Disease Diagnosis , 2015–2025 (USD Million)
    • 7.3. Drug Discovery & Development
      • 7.3.1. Global Whule Genome Amplification Market By Drug Discovery & Development, 2015–2025 (USD Million)
    • 7.4. Research
      • 7.4.1. Global Whule Genome Amplification Market By Research, 2015–2025 (USD Million)
    • 7.5. Agriculture & Veterinary
      • 7.5.1. Global Whule Genome Amplification Market By Agriculture & Veterinary, 2015–2025 (USD Million)
    • 7.6. Forensics
      • 7.6.1. Global Whule Genome Amplification Market By Forensics, 2015–2025 (USD Million)
    • 7.7. Others
      • 7.7.1. Global Whule Genome Amplification Market By Others, 2015–2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Qiagen NV
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Technulogy Portfulio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Sigma-Aldrich
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Technulogy Portfulio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. LGC Group
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Technulogy Portfulio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. GE Healthcare
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Technulogy Portfulio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development

Methodology


Frequently Asked Questions

Surge in the aging population along with increase in the cases of chronic diseases such as arthritis, heart disorders, and cancer will result in humungous growth of whole genome amplification industry over the forecast timeline. A massive rise in the allocation of funds for carrying out clinical trials is expected to offer new opportunities of growth for whole genome amplication industry over the assessment timeline. According to one such study carried out by NIH researchers w.r.t whole genome amplification made from as single cell and from the findings of the study, it has been concluded  that whole genome amplification is useful for diagnosis of genetic disease & forensics as well as accurately analyzing old samples of DNA. This will help in increasing the significance of whole genome amplification and will result in manifold growth of the market in the coming decade.

According to Zion market research report, the global Whole Genome Amplification market, which accrued revenue worth 2.5 (USD Million) in 2019 and anticipated to garner earnings about 4.5 (USD Million) by 2025, is set to grow at a CAGR of nearly 7.9% during the period from 2019 to 2025.

North America is likely to make noteworthy contributions towards overall market size during 2019-2025. The growth of the market in the region over forecast timespan can be credited to massive allocation of funds by the U.S. government for carrying out research pertaining to genetic disorders as well as forensic science. Apart from this, rise in the number of pharma firms in the countries such as Canada and the U.S. focusing on whole genome amplification activities will further proliferate the expansion of whole genome amplification market in the sub-continent over the assessment period.  

The key players profiled in the report include Qiagen NV, LGC Group, Sigma-Aldrich, and GE Healthcare.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social